In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression.

MLA

Ramón Gutiérrez-Casares, José, et al. “In Silico Evaluation of the Role of Lisdexamfetamine on Attention-Deficit/Hyperactivity Disorder Common Psychiatric Comorbidities: Mechanistic Insights on Binge Eating Disorder and Depression.” Frontiers in Neuroscience, July 2023, pp. 1–14. EBSCOhost, https://doi.org/10.3389/fnins.2023.1118253.

APA

Ramón Gutiérrez-Casares, J., Segú-Vergés, C., Sabate Chueca, J., Pozo-Rubio, T., Coma, M., Montoto, C., & Quintero, J. (2023). In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression. Frontiers in Neuroscience, 1–14. https://doi.org/10.3389/fnins.2023.1118253

Chicago

Ramón Gutiérrez-Casares, José, Cristina Segú-Vergés, Juncal Sabate Chueca, Tamara Pozo-Rubio, Mireia Coma, Carmen Montoto, and Javier Quintero. 2023. “In Silico Evaluation of the Role of Lisdexamfetamine on Attention-Deficit/Hyperactivity Disorder Common Psychiatric Comorbidities: Mechanistic Insights on Binge Eating Disorder and Depression.” Frontiers in Neuroscience, July, 1–14. doi:10.3389/fnins.2023.1118253.